Improved Oral Anticoagulation After a Dietary Vitamin K-Guided Strategy A Randomized Controlled Trial

被引:35
|
作者
de Assis, Michelli C. [1 ]
Rabelo, Eneida R. [1 ]
Avila, Christiane W. [1 ]
Polanczyk, Carisi Anne [1 ]
Rohde, Luis E. [1 ]
机构
[1] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Serv Cardiol,Div Cardiovasc, Postgrad Program Cardiol & Cardiovasc Sci, BR-90035003 Porto Alegre, RS, Brazil
关键词
anticoagulants; diet; vitamin K; INTRACRANIAL HEMORRHAGE; RISK-FACTORS; WARFARIN; SENSITIVITY; SUPPLEMENTATION; VARIABILITY; STABILITY;
D O I
10.1161/CIRCULATIONAHA.109.849208
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Dietary vitamin K is thought to be an important factor that interferes with anticoagulation stability, but the clinical applicability of this interaction has not been evaluated adequately in prospective studies. Methods and Results-In a randomized controlled trial that enrolled outpatients with a recent international normalized ratio (INR) outside the therapeutic target, we compared 2 strategies to optimize long-term oral anticoagulation: (1) a conventional approach based on changes in anticoagulant prescription and (2) a dietary vitamin K- guided strategy based on simple modifications of the amount of vitamin K- rich foods ingested per week. The primary efficacy end point was the percentage of patients who achieved a prespecified INR target at 90 days after randomization. Study population (n = 132) predominantly included men with mechanical heart prostheses (58%) or atrial fibrillation (35%). Over time, patients allocated to the vitamin K- guided strategy reached the prespecified INR more frequently so that after 90 days of follow-up, 74% were on target compared with 58% of patients managed conventionally (P = 0.04). Patients allocated to the dietary vitamin K- guided strategy had the same magnitude and direction of INR variation as those observed with the conventional approach in the short term (15 days) for both underanticaogulated and overanticoagulated patients. Minor bleeding or use of parenteral vitamin K were also marginally less frequent in patients managed according to the dietary intervention (1 [1.5%] versus 7 [11%]; P = 0.06). Conclusions-A vitamin K-guided management strategy to adjust long-term oral anticoagulation is feasible and safe and may result in an increased chance of reaching target levels of INR. (Circulation. 2009; 120: 1115-1122.)
引用
收藏
页码:1115 / U143
页数:11
相关论文
共 50 条
  • [21] Vitamin K1 and progression of cardiovascular calcifications in hemodialysis patients: the VitaVasK randomized controlled trial
    Saritas, Turgay
    Reinartz, Sebastian
    Krueger, Thilo
    Ketteler, Markus
    Liangos, Orfeas
    Labriola, Laura
    Stenvinkel, Peter
    Kopp, Christoph
    Westenfeld, Ralf
    Evenepoel, Pieter
    Siepmann, Robert
    Wied, Stephanie
    Hilgers, Ralf-Dieter
    Schurgers, Leon
    Floege, Juergen
    CLINICAL KIDNEY JOURNAL, 2022, 15 (12) : 2300 - 2311
  • [22] Improved Stroke Prevention in Atrial Fibrillation After the Introduction of Non-Vitamin K Antagonist Oral Anticoagulants The Stockholm Experience
    Forslund, Tomas
    Komen, Joris J.
    Andersen, Morten
    Wettermark, Bjorn
    von Euler, Mia
    Mantel-Teeuwisse, Aukje K.
    Braunschweig, Frieder
    Hjemdahl, Paul
    STROKE, 2018, 49 (09) : 2122 - 2128
  • [23] Differential Effects of Oral Boluses of Vitamin D2 vs Vitamin D3 on Vitamin D Metabolism: A Randomized Controlled Trial
    Martineau, Adrian R.
    Thummel, Kenneth E.
    Wang, Zhican
    Jolliffe, David A.
    Boucher, Barbara J.
    Griffin, Simon J.
    Forouhi, Nita G.
    Hitman, Graham A.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2019, 104 (12) : 5831 - 5839
  • [24] Anticoagulation in atrial fibrillation and end-stage kidney disease on hemodialysis: a meta-analysis of randomized trials comparing direct oral anticoagulants with vitamin K antagonists
    Tscharre, Maximilian
    Steiner, Daniel
    Mutschlechner, David
    Ay, Cihan
    Gremmel, Thomas
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2024, 8 (01)
  • [25] Randomized Controlled Clinical Trial of the Effect of Treatment with Vitamin K2 on Vascular Calcification in Hemodialysis Patients (Trevasc-HDK)
    Haroon, Sabrina
    Davenport, Andrew
    Ling, Lieng-Hsi
    Tai, Bee-Choo
    Teo, Lynette-Li-San
    Schurgers, Leon
    Chen, Zhaojin
    Shroff, Rukshana
    Fischer, Dagmar-Christiane
    Khatri, Priyanka
    Low, Sanmay
    Tan, Jia-Neng
    Chua, Horng-Ruey
    Teo, Boon-Wee
    Ong, Ching-Ching
    Subramanian, Srinivas
    Yeo, Xi-Er
    Wong, Weng-Kin
    Lau, Titus-Wai-Leong
    KIDNEY INTERNATIONAL REPORTS, 2023, 8 (09): : 1741 - 1751
  • [26] Patients on vitamin K treatment: is switching to direct-acting oral anticoagulation cost-effective? A target trial on a prospective cohort
    Aebersold, Helena
    Foster-Witassek, Fabienne
    Aeschbacher, Stefanie
    Beer, Juerg H.
    Blozik, Eva
    Blum, Manuel
    Bonati, Leo
    Conte, Giulio
    Coslovsky, Michael
    De Perna, Maria Luisa
    Di Valentino, Marcello
    Felder, Stefan
    Huber, Carola A.
    Moschovitis, Giorgio
    Mueller, Andreas
    Paladini, Rebecca E.
    Reichlin, Tobias
    Rodondi, Nicolas
    Stauber, Annina
    Sticherling, Christian
    Szucs, Thomas D.
    Conen, David
    Kuhne, Michael
    Osswald, Stefan
    Schwenkglenks, Matthias
    Serra-Burriel, Miquel
    OPEN HEART, 2024, 11 (01):
  • [27] Differences in the quality of oral anticoagulation therapy with vitamin K antagonists in German GP practices - results of the cluster-randomized PICANT trial (Primary Care Management for Optimized Antithrombotic Treatment)
    Mertens, Cornelia
    Siebenhofer, Andrea
    Berghold, Andrea
    Pregartner, Gudrun
    Ulrich, Lisa-Rebekka
    Mergenthal, Karola
    Kemperdick, Birgit
    Schulz-Rothe, Sylvia
    Rauck, Sandra
    Harder, Sebastian
    Gerlach, Ferdinand Michael
    Petersen, Juliana Johanna
    BMC HEALTH SERVICES RESEARCH, 2019, 19 (1)
  • [28] Multicenter Randomized Controlled Trial of Vitamin K Antagonist Replacement by Rivaroxaban with or without Vitamin K2 in Hemodialysis Patients with Atrial Fibrillation: the Valkyrie Study
    De Vriese, An S.
    Caluwe, Rogier
    Pyfferoen, Lotte
    De Bacquer, Dirk
    De Boeck, Koen
    Delanote, Joost
    De Surgeloose, Didier
    Van Hoenacker, Piet
    Van Vlem, Bruno
    Verbeke, Francis
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2020, 31 (01): : 186 - 196
  • [29] Efficacy of oral compared with intramuscular vitamin B-12 supplementation after Roux-en-Y gastric bypass: a randomized controlled trial
    Schijns, Wendy
    Homan, Jens
    van der Meer, Leah
    Janssen, Ignace M.
    van Laarhoven, Cees J.
    Berends, Frits J.
    Aarts, Edo O.
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2018, 108 (01) : 6 - 12
  • [30] Real-world data emulating randomized controlled trials of non-vitamin K antagonist oral anticoagulants in patients with venous thromboembolism
    Yoon, Dongwon
    Jeong, Han Eol
    Park, Sohee
    You, Seng Chan
    Bang, Soo-Mee
    Shin, Ju-Young
    BMC MEDICINE, 2023, 21 (01)